-- like FX-322 it is for hair cell regeneration.Can someone summarize what we know about OTO-6XX?
-- their stained photo in the presentation shows both inner and outer hair cells regenerating (the inner hair cell row before and after is especially impressive).
-- it is targeting "severe" hearing loss, unlike FX-322, which will be labelled for up to moderately severe.
-- they haven't released yet how it works or what the compound is
-- they have only recently selected a "lead compound" which means they are further along pre-clinically than they were.